Table 4.

Effects of CCSC on liver and kidney functions in D-gal-treated mice.

	Liver function		Kidney function
	ALT (U/L)	AST (U/L)	BUN (μmoL/L)	CRE (μmoL/L)
Control	31.48 ± 0.85	107.54 ± 2.75	5.44 ± 0.39	25.63 ± 2.03
D-gal	64.41 ± 1.48##	163.62 ± 2.04##	16.47 ± 0.49##	82.36 ± 2.45##
VE	37.21 ± 1.00∗∗	111.44 ± 3.13∗∗	9.78 ± 0.62∗∗	43.00 ± 2.59∗∗
CCSC-L	36.93 ± 0.99∗∗	112.10 ± 3.06∗∗	11.01 ± 1.24∗∗	43.88 ± 3.19∗∗
CCSC-M	40.72 ± 1.09∗∗	117.14 ± 2.74∗∗	9.38 ± 0.51∗∗	41.74 ± 1.99∗∗
CCSC-H	43.73 ± 1.17∗∗	119.55 ± 2.89∗∗	8.89 ± 0.85∗∗	35.15 ± 2.81∗∗

Mean values and standard deviations, n = 10 per group. ^## P < 0.01 compared to the control group. ^∗∗ P < 0.01 compared to the D-gal group.